The posterior bed nuclei of the stria terminalis (BST) are important neural substrate for relaying limbic influences to the paraventricular nucleus (PVN) of the hypothalamus to inhibit hypothalamic-pituitary-adrenal (HPA) axis responses to emotional stress. Androgen receptor-expressing cells within the posterior BST have been identified as projecting to the PVN region. To test a role for androgen receptors in the posterior BST to inhibit PVN motor neurons, we compared the effects of the non-aromatizable androgen dihydrotestosterone (DHT), the androgen receptor antagonist hydroxyflutamide (HF), or a combination of both drugs implanted unilaterally within the posterior BST. Rats bearing unilateral implants were analyzed for PVN Fos induction in response to acute-restraint stress and relative levels of corticotrophin-releasing hormone and arginine vasopressin (AVP) mRNA. Glutamic acid decarboxylase (GAD) 65 and GAD 67 mRNA were analyzed in the posterior BST to test a local involvement of GABA. There were no changes in GAD expression to support a GABA-related mechanism in the BST. For PVN neuropeptide expression and Fos responses, basic effects were lateralized to the sides of the PVN ipsilateral to the implants. However, opposite to our expectations of an inhibitory influence of androgen receptors in the posterior BST, PVN AVP mRNA and stress-induced Fos were augmented in response to DHT and attenuated in response to HF. These results suggest that a subset of androgen receptor-expressing cells within the posterior BST region may be responsible for increasing the biosynthetic capacity and stress-induced drive of PVN motor neurons.
INTRODUCTION
The hypothalamic-pituitary-adrenal (HPA) axis represents a chain of sequentially released hormones from the brain to the periphery that regulates glucocorticoid release from the adrenal (cortisol in human beings, corticosterone in the rat). Elevations in circulating glucocorticoids provide a front line of defense against threats to homeostasis (ie, stress) by mobilizing energy stores in the body to facilitate appropriate autonomic, neuroendocrine, and behavioral responses. Stress activates the HPA axis by initiating the recruitment of neurosecretory neurons in the paraventricular nucleus (PVN) of the hypothalamus to secrete peptide stores from the median eminence, including corticotropinreleasing hormone (CRH) and arginine vasopressin (AVP). Taken together, these neuropeptides synergize on the release of adrenocorticotropin hormone (ACTH) from the anterior pituitary to regulate the synthesis and release of glucocorticoids from the adrenal cortex.
Stress can have positive or negative effects on sex steroid hormone secretion (Gomez et al, 2004; Rivier and Rivest, 1991; Sapolsky, 1986) . Conversely, the magnitude of the HPA response to stress also varies as a function of gonadal status. In male rats, testosterone inhibits ACTH and glucocorticoid release, as well as the stress-induced activation of PVN motor neurons (Handa et al, 1994; Viau et al, 2003; Viau and Meaney, 1991) . Likewise, testosterone and its metabolites introduced into the vicinity of the PVN and in the medial preoptic nucleus inhibit HPA axis responses (Lund et al, 2006; Viau and Meaney, 1996; Williamson et al, 2010) .
However, several additional forebrain and hypothalamic structures that project to the PVN and/or regulate ACTH release also contain a high number of sex steroid hormone receptors (Williamson and Viau, 2007) . This suggests that there is likely a complex network dedicated to the central actions of testosterone on HPA axis responses. Determining the neurocircuitry and mechanisms by which testosterone acts in the brain to modulate HPA function is crucial for understanding individual and sex-based differences in susceptibility to stress-related disorders.
In contrast to nuclei supplying sensory information to the HPA axis, limbic-emotional pathways to the PVN are indirect and rely upon various forebrain and hypothalamic relays, including the bed nuclei of the stria terminalis (BST) (Cullinan et al, 1993; Dong and Swanson, 2004; Gu et al, 2003; Sawchenko and Swanson, 1983) . Lesions studies suggest that cells occupying the posterior division of the BST inhibit PVN and HPA responses, likely provided by GABAergic inputs (Choi et al, 2007) . The posterior BST contains one of the highest densities of sex steroid hormone receptors in the forebrain (Shughrue et al, 1997; Simerly, 1993) , and a significant complement of PVN-projecting cells in this region contain the androgen receptor (Williamson and Viau, 2007) . Furthermore, the posterior BST also sends projections back to the amygdalar and lateral septal nuclei, both of which are putative regulators of the HPA axis. Collectively, these findings implicate the posterior BST as an important site of interaction between sex steroid hormone and limbic influences on the HPA axis.
The posterior BST is sexually dimorphic, with male rats showing a greater numbers of cells and higher projection densities compared with female rats (de Vries, 2008) . Testosterone exposure during the perinatal period has been shown in adult male rats to increase the size and number of cells in the principle nucleus of the posterior BST (Guillamon et al, 1988) . Moreover, the inhibitory effect of neonatal testosterone on adult PVN and HPA responses to stress is associated with increased numbers of androgen receptors in the posterior BST (Bingham and Viau, 2008) .
On the basis of these findings, we previously proposed that androgen receptors in the posterior BST could contribute to the upstream influences of testosterone on the PVN and its extended circuitries (Bingham et al, 2006; Bingham and Viau, 2008) . To test this hypothesis, in this study we measured neuropeptide expression levels under basal conditions and Fos responses to acute restraint stress in PVN, lateral septum, and amygdalar nuclei in male rats bearing discrete unilateral implants of androgen steroid and/or antagonist into the posterior BST region. As GABA neurotransmission is sensitive to androgens and plays a significant role in limbic regulation of the PVN, we also assessed glutamic acid decarboxylase (GAD) expression in the posterior BST. Unilateral implants were chosen over a bilateral approach to take advantage of the unilateral projection profiles of the posterior BST and to avoid possible secondary effects attributed to alterations in adrenal corticosteroid responses. PVN responses to stress vary as a function of testosterone levels in circulation (Viau et al, 2003) . Thus, to credit drug effects primarily to changes in androgen receptor occupancy in the posterior BST, we superimposed castration plus low physiological levels of testosterone replacement.
MATERIALS AND METHODS

Animals
Fifty-eight adult male Sprague-Dawley rats (Harlan Laboratories, Indianapolis, IN) were used. Animals were pair-housed under controlled temperature and lighting conditions (12 h light/dark schedule, lights on at 0700 hours), with food (Rad diet 5012, Lab Diet) and water available ad libitum. Animals were subjected to experimental procedures at 70 days of age, and then handled daily until testing. All experimental protocols were approved by the University of British Columbia Animal Care Committee.
Adult Testosterone Replacement
To reveal a dependency of PVN neurons on androgen receptors in the posterior BST, animals were castrated at 70 days of age and implanted with subcutaneous capsules designed to deliver stable concentrations of testosterone in circulation. Testes were removed under isoflurane anesthesia, during which animals received a single subcutaneous Silastic capsule (inner diameter 1.57 mm, outer diameter 3.18 mm, length 7.5 mm), packed with crystalline testosterone. The size of this capsule produces stable, physiological levels of testosterone in the order of 0.5 ng/ml (Williamson and Viau, 2008) . This level of testosterone replacement was chosen to detect effects mediated by local changes in androgen receptor signaling in the posterior BST while sustaining low background levels of androgen receptor occupancy within other brain regions.
Intracerebral Microimplants
At 1 week after testes removal and testosterone replacement, animals received stereotaxically guided, unilateral microimplants of the non-aromatizable androgen dihydrotestosterone (DHT; Sigma Chemicals, Oakville, ON, Canada), the androgen receptor antagonist hydroxyflutamide (HF; Toronto Research Chemicals, North York, ON, Canada), or a mixture of both drugs under isoflurane anesthesia. Twenty-two-gauge cannula ejectors were aimed to terminate within the centrolateral part of the posterior division of the BST, biased towards the medial border of the descending limb of the internal capsule. The coordinates chosen (see below) were designed to target the major androgen receptor-containing nuclei of the posterior BST, but aimed far enough to be removed from the medial zone of the hypothalamus to avoid drug delivery to the medial preoptic area and the rostral part of the PVN (see Results).
Coordinates for proper implant placement in the posterior BST were first piloted using the distribution of androgen receptors induced by DHT and HF in castrated male rats 2 weeks after stereotaxic surgery. As androgen receptor staining is abolished or restricted to the cytoplasm following removal of endogenous testosterone, we used the pattern and quality of staining to provide an index of transport and delivery. Coordinates used for proper placement in experimental animals were 0.15 mm caudal to bregma, 1.5 mm lateral to the midline, and 6 mm ventral from the pia. Drugs were dissolved in a heated suspension of beeswax (VWR International, Buffalo Grove, IL) to a final concentration of 0.3 M (Christensen and Gorski, 1978; Lund et al, 2006) , packed to a height of 400 mm, and ejected using a 28-gauge wire that extended 0.5 mm beyond the tip of the ejector cannula. This delivery method is able to induce androgen receptors for at least 2 weeks (see Williamson et al, 2010) . Control animals received unilateral implants of beeswax alone. To avoid functional differences attributed to laterality, half of the animals received unilateral implants on either the left or right sides of the posterior BST.
Blood Sampling and Hormone Assays
At 2 weeks after stereotaxic surgery, plasma testosterone and corticosterone were measured under basal conditions and at 30 min of restraint to verify the concentration and stability of testosterone replacement, as well as to survey possible implant effects on HPA outflow. Blood samples were obtained via the tail vein immediately after removal from the home cage and/or at the termination of a single exposure to stress, which involved placing rats into flat bottom Plexiglas restrainers (8.5 Â 21.5 cm 2 ; Kent Scientific, Litchfield, CT). The 30 min sampling time point is reliable for detecting central influences of androgens on HPA outflow and PVN Fos responses (Viau et al, 2003) . Plasma testosterone (25 ml) and corticosterone (5 ml) concentrations were measured using commercial RIA kits and 125 I-labeled ligands (MP Biomedical, Solon, OH). The intra-and interassay coefficients of variation for both assays ranged from 3 to 6 and 10 to 12%, respectively. The standard curve ED-50 for the testosterone RIA was 1.2 ng/ml, with a detection limit of 0.1 ng/ml. The standard curve ED-50 for the corticosterone RIA was 17 mg/dl, with a detection limit of 0.625 mg/dl.
Perfusion and Tissue Processing
Immediately after blood sampling, rats were perfused under deep chloral hydrate anesthesia (350 mg/kg, intraperitoneal), reliably achieved within 1-2 min of drug administration. Rats were perfused via the ascending aorta with ice-cold 0.9% saline and then 4% paraformaldehyde (pH 9.5). Brains were post-fixed for 4 h and stored overnight with 15% sucrose in 0.1 M potassium PBS (KPBS, pH 7.3) before slicing. Five 1-in-5 series of frozen 30-mm-thick coronal sections were collected through the length of the brain and stored at À201C in cryoprotectant (30% ethylene glycol and 20% glycerol). Adjacent tissue series from individual animals were used for separate immunocytochemical and in situ hybridization analyses.
Immunohistochemistry
Androgen receptor-immunoreactivity (-ir) was localized using a primary antiserum (0.025 mg/ml; 1 : 8k) raised against the androgen receptor (sc-816, Lot. number E1004; Santa Cruz Biotechnology, Santa Cruz, CA). Restraintresponsive neurons were localized employing Fos-ir as a marker of cellular activation using a primary antiserum (1 : 40k) raised against the human Fos protein (Ab-5, Lot. number 4191-1-1; Oncogene Research Products, Boston, MA). Conventional nickel-intensified, avidin-biotin-immunoperoxidase (Vectastain Elite ABC kit; Vector laboratories, Burlington, CA) procedures were used for both Fos and androgen receptor detection. Total cell number estimates of Fos-ir cells were generated by counting the number of positive cells per region, averaged for slice number, corrected for double counting errors (Guillery, 2002) , and multiplying this product by a factor of five to account for slice frequency (one in five sections).
Hybridization Histochemistry
Described in greater detail elsewhere (Simmons et al, 1989; Williamson et al, 2010) , an in situ hybridization approach was employed using 33 P-UTP-labeled (GE Healthcare BioSciences, Baie d'Urfe, QC, Canada) antisense cRNA probes to determine relative levels of CRH and AVP mRNA in the PVN and in central and medial amygdala nuclei, respectively, and for the AVP transcript in the posterior BST. The CRH mRNA probe was transcribed from a full-length (1.2 kb) cDNA encoding the rat CRH gene (Dr K Mayo, Northwestern University, Evanston, IL). The AVP mRNA probe was transcribed from a 230-bp fragment of the 3 0 end of exon C encoding the rat vasopressin gene (Dr D Richter, University of Hamburg, Hamburg, Germany).
Of the two GABA-synthesizing enzymes, GAD enzyme 65 and 67 kDa isoforms, a single episode of restraint causes a preferential and transient increase in GAD 67 mRNA levels. In contrast, repeated restraint causes a selective increase in basal GAD 65 mRNA levels (Bowers et al, 1998) . Taken as markers of state-dependent and de novo changes in GABA synthesis, relative levels of GAD 65 mRNA under basal conditions and GAD 67 mRNA after 30 min of restraint, respectively, were assessed in the posterior BST using fulllength probes for mRNA encoding GAD 65 and GAD 67 (2.01 and 2.7 kb, respectively; Dr A Tobin, University of California, Los Angeles, Los Angeles, CA) (Erlander et al, 1991) .
Parceling of the rat brain, as defined by the morphological features provided by thionin staining, was based on the terminology of Swanson (2004) , and of Swanson and coworkers to describe the PVN (Swanson and Kuypers, 1980) , posterior BST (Dong and Swanson, 2004) , and central and lateral amygdala (Canteras et al, 1995; Dong et al, 2001) , and of Li and Sawchenko (1998) to describe the lateral septum. Localization of transcripts and Fos-ir to different regions of the PVN was defined by redirected sampling of Nissl staining patterns aligned to adjacent corresponding dark-and bright-field images (Viau and Sawchenko, 2002) . Light-and dark-level images were captured using a Retiga 1300 CCD digital camera (Q-imaging, Burnaby, BC, Canada), analyzed using Macintosh OS X-driven, Open Lab Image Improvision software (version 3.0.9, Quorum Technologies, Guelph, ON, Canada) and Image J software (version 1.38, NIH, Bethesda, MD).
Statistics
Group data from the hormone assays were compared using a two-way (between-treatment, within-subject) mixeddesign ANOVA using time as the repeated measure. As comparisons were made between control and implant sides of the brain, immunoperoxidase and hybridization analyses were compared using a two-way (between-treatment, within-subject) mixed-design ANOVA using side as the repeated measure. When main effects and interactions between treatment and side were found to be significant (Po0.05), additional comparisons were made using Newman-Keuls post hoc test. Data were analyzed using the Aabel Gigawiz statistical software (version 3.0.4) using absolute measures in all cases. To underscore effects lateralized to the sides of the nuclei ipsilateral to the posterior BST implants, data are illustrated as the mean ± SEM percentage of the contralateral (non-implanted) side. Comparisons were made observer-blind by assigning coded designations to data and tissue sets in advance.
RESULTS
Implant Placements
On the basis of the pattern of androgen receptor staining induced by DHT and HF in castrated male rats, the radius of drug transport was fairly consistent between animals and never exceeded greater than 400-500 mm from the edge of the implants. Animals bearing proper implants of DHT showed induction of androgen receptor staining within each of the major nuclei of the posterior BST, confined to the ipsilateral side (Figure 1 ). The distribution and intensity of nuclear staining was comparable in animals bearing HF implants, suggesting similar transport and uptake (data not shown, see Williamson et al (2010) ). Androgen receptor induction was not detectable within periventricular structures or within the adjacent medial preoptic nucleus, which normally contains a high concentration of androgen receptors and provides an inhibitory influence on HPA effector neurons of the PVN (Williamson and Viau, 2008) . No lateralized effects were observed for androgen receptor staining within the PVN proper and surround, or within cells occupying the anterior division of the BST. Experimental animals showing implants that missed the intended centrolateral part of the posterior BST or placement to suggest ventricular contamination were removed from subsequent analyses. On the basis of these exclusion criteria, a final n value of 5 was achieved for each of the BST implant groups.
Local DHT implants in the brain have been shown to modestly increase AVP expression within the posterior BST (Brot et al, 1993; de Vries et al, 1986) . Thus, relative levels of AVP mRNA were assessed as a function of treatment status to confirm local drug delivery. There were no significant effects of treatment (F(3, 16) ¼ 0.22; P40.5) and side (F(1, 16) ¼ 0.56; P ¼ 0.47), but a significant interaction between treatment and side (F(3, 16) ¼ 4.53; P ¼ 0.02). The basis for the interaction occurred in animals bearing DHT implants, who showed higher levels of the AVP transcript on the ipsilateral compared with the contralateral side of the posterior BST (Figure 2 ). This lateralized response did not occur in animals bearing a mixture of DHT and HF, indicating an androgen receptor requirement for the effect of DHT. Collectively, these findings provide a functional Figure 1 Representative bright-field photomicrographs to show the unilateral induction of androgen receptor (AR) staining after implants of dihydrotestosterone (DHT) in castrated male rats. Low magnification view (a) shows that AR induction is restricted to the major nuclei of the posterior bed nuclei of the stria terminalis (BST), ipsilateral (left), but not contralateral (right) to the side of the DHT implant. Enlarged views of the boxed regions to show nuclear staining for AR within the ipsilateral (b), but not the contralateral BST (c), whereas AR staining is diffusely located within the cytoplasm of the adjacent (d) and contralateral (e) medial preoptic nucleus (MPN). Scale bar ¼ 40 mm for (b-e) and 400 mm in (a). indication that the posterior BST was effectively targeted in the experimental animals chosen for analysis.
Critically, as with all of the parameters of interest in this study (see Results), there was no lateralized effect for AVP expression in control animals bearing unilateral implants of beeswax to suggest the possibility of space-occupying lesions. For any effect observed, we found no differences between implants placed on the left compared with the right side of the posterior BST.
Plasma Hormone Levels
For testosterone, there were no significant effects of treatment (F(3, 16) ¼ 0.31; P40.5) and stress (F(1, 16) ¼ 1.53; P ¼ 0.23), and no significant interaction between treatment and stress (F(3, 16) ¼ 1.34; P ¼ 0.29). Collapsing across the 0 and 30 min time points, mean ± SEM plasma testosterone concentrations were: control, 0.49 ± 0.03 ng/ml; DHT, 0.47±0.02 ng/ml; HF, 0.46±0.4 ng/ml), and DHT + HF, 0.51±0.04 ng/ml. On the basis of a previous report employing testosterone capsules similar to our own (Singh et al, 2000) , we would estimate plasma DHT concentrations in the order of 0.02 ng/ml. Thus, our replacement strategy provided background androgen levels that were stable and sufficiently low enough across treatment groups to credit drug effects primarily to local changes in androgen receptor occupancy in the posterior BST.
As illustrated in Figure 3 , plasma corticosterone concentrations were reliably increased by restraint exposure (F(1, 16) ¼ 252.12; Po0.0001). As expected, there was no significant effect of treatment (F(3, 16) ¼ 0.25; P40.5) and no significant interaction between treatment and time (F(3, 16) ¼ 0.36; P40.5) to suggest an influence of the unilateral implants to modulate HPA outflow. It is also worth noting that corticosterone and testosterone in circulation can interact on PVN motor neuron drive (Viau et al, 1999) . Taken together, the hormone data validate our combined BST and peripheral implant approach, as it allows us to study the effects of androgen receptors in the posterior BST in isolation of other potential sources of androgen-and glucocorticoid-sensitive input to the PVN.
Implant Effects on Neuropeptide Expression
CRH and AVP mRNA in the PVN. Densitometric analysis of the relative levels of CRH mRNA in the hypophysiotropic, dorsal medial parvicellular (mpd) compartment of the PVN (Figure 4 , bottom panels) revealed no significant effects of treatment (F(3, 16) ¼ 1.92; P ¼ 0.17) and side (F(1, 16) ¼ 0.04; P40.5), and no significant interaction between treatment and side (F(3, 16) ¼ 2.22; P ¼ 0.13) under basal conditions. With respect to AVP (Figure 3 , top panels), materials from the same experiment revealed no significant effect of treatment (F(3, 16) ¼ 2.01; P ¼ 0.16). However, there was a significant effect of side (F(1, 16) ¼ 23.25; P ¼ 0.0002) and a significant interaction between treatment and side (F(3, 16) ¼ 36.74; Po0.0001). The basis for the effect of side and the interaction occurred as a consequence of relatively higher levels of AVP mRNA within the DHT group and relatively lower levels of AVP mRNA within the HF group, on the sides of the PVN ipsilateral to the BST implants (Figure 4 , top panels). There was no lateralized effect in animals receiving DHT and HF combined, confirming a role for the androgen receptor to mediate the stimulatory influence of DHT.
CRH and AVP mRNA in the amygdala. CRH and AVP mRNA in the central and medial nuclei of the amygdala, respectively, increase in response to elevations of testosterone in circulation (Viau et al, 2001) . As both of these regions are densely innervated by the posterior BST, the relative levels of these transcripts were surveyed as a function of treatment status under basal conditions. For the CRH transcript in the central nucleus, there were no significant effects of treatment (F(3, 16) ¼ 1.01; P ¼ 0.41) and side (F(1, 16) ¼ 2.42; P ¼ 0.14), and no significant interaction between treatment and side (F(3, 16) ¼ 1.24; P ¼ 0.19). For the AVP transcript in the medial nucleus, there were no significant effects of treatment (F(3, 16) ¼ 0.26; P40.5) and side (F(1, 16) ¼ 0.39; P40.5), and no significant interaction between treatment and side (F(3, 16) ¼ 0.34; P40.5). The negative findings for CRH may be explained by the prominence of posterior BST projections to the medial, but not the lateral CRH-expressing part of the central amygdalar nucleus (Honkaniemi et al, 1992) . The lack of effect on AVP provides reassurance that the medial preoptic nucleus was effectively avoided by the BST implants, as testosterone implants in the vicinity of the medial preoptic nucleus stimulate AVP mRNA levels in the medial amygdala (Williamson et al, 2010) .
Implant Effects on Activational Responses to Acute Restraint Stress
Mpd region of the PVN. Control animals expressed few, if any, Fos-ir neurons in the PVN under basal conditions. No main effects or interactions were revealed for any of its major divisions. Restraint-induced Fos-ir was concentrated within the PVN mpd region ( Figure 5 ), with few to scattered labeling within the autonomic-related subdivisions and in the posterior magnocellular division of the PVN. For the mpd region, there were no significant effects of treatment (F(3, 16) ¼ 2.32; P ¼ 0.11) and side (F(1, 16) ¼ 2.90; P ¼ 0.11), but a significant interaction between treatment and side (F(3, 16) ¼ 4.99; P ¼ 0.012). The basis for this interaction occurred as a consequence of relatively higher numbers of Fos-positive cells in the DHT group and lower numbers in the HF group, focused on the sides of the PVN ipsilateral to the BST implants ( Figure 5 ). No lateralized effects occurred for stress-induced Fos in animals bearing a mixture of DHT and HF implants in the posterior BST.
Lateral septum and medial amygdala. The posterior BST issues prominent projections to the lateral septum and medial amygdala (Dong and Swanson, 2004; Gu et al, 2003) . Each of these, in turn, is capable of regulating PVN motor neurons (Herman et al, 2003) . Therefore, we extended our survey to these regions using the same material used for the PVN under basal and stress conditions. For both the lateral septal and medial amygdala nuclei in unstressed animals, there were no effects of treatment and side, and no interactions between treatment and side (P40.5 in all cases).
In animals exposed to restraint, there were no significant effects of treatment (F(3, 16) ¼ 1.51; P ¼ 0.25) and side (F(1, 16) ¼ 1.97; P ¼ 0.18), and no significant interaction between treatment and side (F(3, 16) ¼ 0.90; P ¼ 0.46) to suggest that androgen receptors in the posterior BST influence Fos responses within the lateral septal nucleus. For the medial amygdala, Fos induction was most prominent within the posterodorsal part, with fewer cells detected in the posteroventral and anteroventral parts of the nucleus (Figure 6 ). Focused within the posterodorsal part of the medial amygdala, there was no significant effect of treatment (F(3, 16) ¼ 0.29; P40.5), but a significant effect of side (F(1, 16) ¼ 13.78; P ¼ 0.0019) and a significant interaction between treatment and side (F(3, 16) ¼ 9.33; P ¼ 0.008). The basis for the effect of side and the interaction occurred as a consequence of higher number of Fos-positive cells in the DHT group, on the sides of the medial amygdala ipsilateral to the BST implants ( Figure 6 ). There were no lateralized effects for Fos-ir in animals bearing HF alone or DHT and HF implants combined. 
GAD 65 and GAD 67 mRNA Expression in the Posterior BST
Stressed induced changes in GABA neurotransmission within PVN-projecting populations have been proposed to provide a mechanism for regulating PVN and HPA axis responses (Herman et al, 2005) . GAD expression and activity within several brain regions is altered by testosterone in circulation (Searles et al, 2000) , as well as by restraint stress (Bowers et al, 1998) . Prompted by the strength to which the PVN responded to the DHT implants, we anticipated a local influence for androgen receptors to regulate GAD mRNA expression in the posterior BST. For the GAD 65 isoform in unstressed animals, there were no significant effects of treatment (F(3, 16) ¼ 0.45; P40.5) and side (F(1, 16) ¼ 3.0; P ¼ 0.18), and no significant interaction between treatment and side (F(3, 16) ¼ 0.038; P40.5). For the GAD 67 isoform in animals exposed to restraint, there were no significant effects of treatment (F(3, 16) ¼ 2.56; P ¼ 0.19) and side (F(1, 16) ¼ 2.34; P ¼ 0.14), and no significant interaction between treatment and side (F(3, 16) ¼ 0.26; P40.5). Collectively, these results suggest that the stimulatory effects of DHT on PVN responses are not predicted by local preemptive or stress-induced changes in GABA synthesis in the posterior BST.
DISCUSSION
Lesion studies indicate that the posterior BST inhibits HPA axis responses to stress and PVN-projecting neurons in this region contain a high density of androgen receptors. We anticipated, therefore, a role for androgen receptors within the posterior BST to inhibit central indices of HPA function. We exploited the unilateral projection profile of the posterior BST by introducing unilateral implants of the androgen DHT, or the androgen receptor blocker HF into the posterior BST region. The posterior BST contains estrogen receptors (Shughrue et al, 1997; Simerly et al, 1990) and has the capacity to convert testosterone and its metabolites to estrogen (Lund et al, 2006; Zhao et al, 2007) . Therefore, to determine the sex steroid hormone receptor basis for the effects of DHT, our study also included an additional group of animals receiving an admixture of DHT and HF.
We initially considered removing all sources of androgens by employing castrated animals for our studies. Androgen receptors are contained within a massive array of cell groups identified as projecting to the PVN, as well as to the posterior BST. Moreover, testosterone and its metabolites have been shown to exert local effects in the vicinity of the PVN in addition to the medial preoptic nucleus, which also communicates with the PVN and the posterior BST. Finally, castration stimulates all levels of the HPA axis, as well as neuropeptide expression within multiple afferent regulators of the PVN (Viau et al, 2003) . Rather than testing the influence of the posterior BST to counteract or compete with a global stimulatory influence of castration on the PVN and its extended circuitries, we chose instead to use castrated animals replaced with low physiological levels of testosterone. By supplying the remainder of the brain with low background levels of testosterone, this allowed us to credit drug effects primarily to local changes in androgen receptor signaling in the posterior BST.
In line with the unilateral projections of the posterior BST, the basic effects of the implants were lateralized to the sides of the PVN ipsilateral to the posterior BST implants. In unstressed animals, DHT and HF implants exerted stimulatory and inhibitory effects, respectively, on AVP mRNA within in the PVN mpd region. However, there was no effect of drug treatment on CRH expression in the PVN. As with our previous transcriptional, median eminence content, and immunohistochemical studies (reviewed by Williamson et al (2005) , and see Williamson and Viau (2008) ), the current results continue to suggest that androgens act in the brain to selectively target the capacity of PVN neurons to synthesize AVP.
Opposite to our expectations, stress-induced Fos protein responses in the PVN were increased in response to DHT and decreased in response to HF implants. Moreover, the opposing influences of these drugs were restricted to the mpd HPA-regulating zone of the PVN. No such lateralized effects were observed in animals receiving a mixture of DHT and HF, confirming an androgen receptor mode of action for DHT.
The posterior division of the BST has three major nuclei: principal, interfascicular, and transverse, all of which contain androgen receptors (see Figure 7) . However, it is the principle nucleus that preferentially innervates the medial parvicellular HPA-regulating zone of the PVN (Gu et al, 2003) . The transverse nucleus innervates, at best, the anterior parvicellular part of the PVN (Dong and Swanson, 2004) . The interfascicular nucleus innervates regions immediately adjacent to the PVN proper (Dong and Swanson, 2004) , and is in a position to influence limbic inputs to the HPA axis, albeit indirectly. Thus, AVP mRNA and cellular activation of the PVN may depend on androgen receptors in both the principle and interfascicular nuclei, although the precise origin of this influence still remains unknown (Williamson and Viau, 2007) .
Separate populations in the posterior BST project back to a variety of limbic-forebrain regions implicated in HPA axis control, including the lateral septal and adjacent medial amygdala nuclei (Dong and Swanson, 2004) . Both of these regions project extensively to BST and/or hypothalamic neurons relaying information to the PVN proper and surround, and are in a position to modulate PVN and HPA responses to restraint stress (Herman et al, 2003 (Herman et al, , 2005 . There were no lateralized effects for stress-induced Fos in the lateral septum to suggest a dependency on androgen receptors in the posterior BST. However, DHT caused a HF-reversible increase in the number of cells recruited to express Fos protein on the side of the medial amygdala ipsilateral to the side of the BST implants. We have yet to map the containment of androgen receptors within posterior BST identified as projecting to the medial amygdala. Nonetheless, our data suggest that the increase in cellular activation in the medial amygdala in response to DHT is predictive of driving PVN responses to stress and dependent on androgen receptors in the posterior BST.
The results support a role for androgen receptors in the posterior BST to provide a stimulatory influence on the PVN, as well as its extended circuitries. However, this still leaves open the question as to why targeted lesions of the posterior BST suggest an involvement for this region in HPA axis inhibition (Choi et al, 2007) . Also in contrast to these results, we had previously observed an inverse relationship between the number of androgen receptors in the posterior BST and the magnitude of the HPA axis response to stress (Bingham and Viau, 2008) . Towards explaining these dissenting findings, as previously raised by Dong and Swanson (2004) , any one of the major cell groups of the posterior BST could have distinctive capacities for responding to local changes in androgen exposure. In other words, our findings may speak to a smaller subset of androgen-sensitive neurons in the posterior BST that are uniquely responsible for regulating the PVN. If diminutive in size relative to the remaining number of PVN afferents, this could also reconcile the predominately stimulatory effect of posterior BST lesions on PVN and HPA stress axis responses.
As a final consideration, testosterone in circulation would naturally be expected to impact the posterior BST bilaterally. Thus, our unexpected results may be unique to the unilateral conditions imposed. Therefore, whether bilateral implants of DHT into the BST might continue to reflect stimulatory effects on PVN motor neuron function is worthy of pursuit, in addition to HPA output. Nonetheless, given the inherent difficulties in attributing changes in HPA outflow to central interactions between androgens and corticosteroids, our current approach provides a critical first step in understanding how androgen receptors in the BST operate on the PVN independent of secondary physiological responses.
PVN neurons are richly innervated by GABAergic cell populations from the posterior BST (Polston et al, 2004) . Further, GABA synthesis and turnover in the brain is remarkably sensitive to alterations in circulating testosterone concentrations (Grattan and Selmanoff, 1993) . Thus, we anticipated a local influence for androgen receptors to regulate GAD expression in the posterior BST. However, there were no lateralized effects on GAD 65 and GAD 67 mRNA levels to suggest a mechanism of GABA disinhibition, as previously proposed for other sources of GABAergic influences on the PVN (Herman et al, 2005) . In agreement with the these negative results, GAD expression and activity in the posterior BST appear to be under the control of descending limbic inputs to this region (Mueller et al, 2006) , as well as by estrogen metabolites of testosterone (Earley and Leonard, 1978) .
The posterior BST hosts a variety of neurotransmitters and neuropeptides, including AVP (de Vries et al, 1984) , CCK (Micevych et al, 1988) , substance P (Malsbury and McKay, 1987) , galanin (Planas et al, 1995) , enkephalin, and glutamate (Poulin et al, 2009) . The expression of several of these phenotypes is altered by sex hormones in both male and female rats (de Vries and Miller, 1998; Simerly et al, 1989) . Any one of these may represent a candidate mediator for the effects of androgens on PVN responses. However, the connectivity of these neurotransmitters and neuropeptides in Figure 7 Based on previous connectivity studies and our current findings, this schematic illustrates candidate circuits mediating the stimulatory effects of dihydrotestosterone (DHT) in the posterior bed nuclei of the stria terminalis (BST) on the paraventricular nucleus (PVN) of the hypothalamus. These results support a direct pathway from the principle (pr) nucleus of the posterior BST to the neuroendocrine (medial parvocellular) part of the PVN. The posterodorsal part of the medial amygdala (MEApd) and interfascicular (if) nucleus of the posterior BST do not innervate the neuroendocrine part of the PVN, but innervate the area surrounding the PVN (shaded regions). Both of these components may be in a position to regulate input from other limbic regions, albeit indirectly. In contrast to our current findings, androgen receptors in medial preoptic nuclei inhibit the PVN (dashed line). Thus, the central effects of androgens on hypothalamic-pituitary-adrenal (HPA) axis responses to stress may reflect the net of stimulatory and inhibitory influences on PVN motor neuron drive.
Androgen receptors and central stress pathways B Bingham et al reference to PVN projecting neurons and identity with respect to androgen receptors has not been fully explored. On the basis of previous anatomical and functional evidence, the posterior BST has been interpreted to be involved in the control of reproductive and social behavior (see Dong and Swanson, 2004) . In light of our current findings, the posterior BST may very well represent an important locus for registering situation-specific changes in gonadal status and distributing this information to both the reproductive and adrenal axes.
We are not about to conclude that the posterior BST registers changes in circulating testosterone solely to provide a stimulatory influence on PVN motor neuron responses. Rather, we propose that the net effect of testosterone to regulate PVN motor responses is determined by the relative contributions of different projection neurons in the posterior BST and their capacities for expressing estrogen and androgen receptors (see Dong and Swanson (2004) ). Estrogen and testosterone in circulation cause opposing stimulatory and inhibitory influences, respectively, on the HPA axis (Lund et al, 2004; Viau and Meaney, 1991) . Therefore, it would be helpful to determine whether the major nuclei of the posterior BST possess different propensities for metabolizing testosterone to estrogens and other androgenic forms.
In this same context, and in contrast to our current findings, androgens have been shown to act at the level of the medial preoptic nucleus and within the vicinity of the PVN region to inhibit stress PVN and HPA activity (Lund et al, 2006) . As the magnitude of the HPA axis response to stress has been postulated to reflect the net influence of stimulatory and inhibitory drive to the PVN, androgen receptor signaling in the posterior BST could contribute to the positive arm of this regulation. This may be of particular importance to conditions of chronic stress, where energetic demands are greater and a full HPA response is necessary for survival (Gomez and Dallman, 2001; Gray et al, 2010) . Under these conditions, we propose that the posterior BST might be engaged to temper the inhibitory effect of circulating testosterone on HPA output. Thus, the extent to which the posterior BST is recruited to register and translate the effects of testosterone to the HPA axis may ultimately depend on the type, intensity, and duration of stress exposure. All of these variables contribute to stress pathology, including affective and physiological disorders.
We are only beginning to understand how the posterior BST mediates the distal effects of androgens on the PVN. The current results suggest that the posterior BST is not just a recipient of descending limbic influences, but also an important neural substrate capable of reciprocating androgen-sensitive information to upstream modulators of the HPA axis. Our unanticipated findings highlight the need for further systematic evaluation of central sex steroid hormone influences on the HPA axis. Studies of this nature will continue to provide a critical framework for understanding the basis for individual differences in stress resilience and predisposition to disease.
